Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological …
RA Soslow, C Tornos, KJ Park, A Malpica… - International journal …, 2019 - journals.lww.com
In this review, we sought to address 2 important issues in the diagnosis of endometrial
carcinoma: how to grade endometrial endometrioid carcinomas and how to incorporate the …
carcinoma: how to grade endometrial endometrioid carcinomas and how to incorporate the …
Endometrial cancer
F Amant, P Moerman, P Neven, D Timmerman… - The Lancet, 2005 - thelancet.com
Each year, endometrial cancer develops in about 142 000 women worldwide, and an
estimated 42 000 women die from this cancer. The typical age-incidence curve for …
estimated 42 000 women die from this cancer. The typical age-incidence curve for …
Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer—combined analysis of the PORTEC cohorts
E Stelloo, RA Nout, EM Osse, IJ Jürgenliemk-Schulz… - Clinical cancer …, 2016 - AACR
Purpose: Recommendations for adjuvant treatment for women with early-stage endometrial
carcinoma are based on clinicopathologic features. Comprehensive genomic …
carcinoma are based on clinicopathologic features. Comprehensive genomic …
[PDF][PDF] ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma,
A Rodolakis, G Scambia, F Planchamp… - Human …, 2023 - academic.oup.com
STUDY QUESTION How should fertility-sparing treatment of patients with endometrial
carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were …
carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were …
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non …
RA Nout, V Smit, H Putter, IM Juergenliemk-Schulz… - The Lancet, 2010 - thelancet.com
Background After surgery for intermediate-risk endometrial carcinoma, the vagina is the
most frequent site of recurrence. This study established whether vaginal brachytherapy …
most frequent site of recurrence. This study established whether vaginal brachytherapy …
Molecular genetics of endometrial carcinoma
DW Bell, LH Ellenson - Annual Review of Pathology …, 2019 - annualreviews.org
Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United
States. Endometrioid endometrial carcinomas constitute approximately 85% of newly …
States. Endometrioid endometrial carcinomas constitute approximately 85% of newly …
Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification
JC Kasius, JMA Pijnenborg, K Lindemann, D Forsse… - Cancers, 2021 - mdpi.com
Simple Summary Endometrial cancer (EC) is the most common gynaecologic malignancy in
developed countries. Most patients are sufficiently treated with removal of uterus, tubes and …
developed countries. Most patients are sufficiently treated with removal of uterus, tubes and …
[HTML][HTML] Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma
CL Creutzberg, RA Nout, MLM Lybeert… - International Journal of …, 2011 - Elsevier
PURPOSE: To evaluate the very long-term results of the randomized Post Operative
Radiation Therapy in Endometrial Carcinoma (PORTEC)-1 trial for patients with Stage I …
Radiation Therapy in Endometrial Carcinoma (PORTEC)-1 trial for patients with Stage I …
Accuracy of endometrial sampling in endometrial carcinoma: a systematic review and meta-analysis
NCM Visser, C Reijnen, LFAG Massuger… - Obstetrics & …, 2017 - journals.lww.com
OBJECTIVE: To assess the agreement between preoperative endometrial sampling and
final diagnosis for tumor grade and subtype in patients with endometrial carcinoma. DATA …
final diagnosis for tumor grade and subtype in patients with endometrial carcinoma. DATA …
[HTML][HTML] Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
G Bredholt, M Mannelqvist, IM Stefansson… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Aims Tumor necrosis is associated with aggressive features of endometrial cancer and poor
prognosis. Here, we investigated gene expression patterns and potential treatment targets …
prognosis. Here, we investigated gene expression patterns and potential treatment targets …